Arkolith/Insider Trading/ATTO/Form 4

venBio Global Strategic Fund IV, L.P.

10% OwnerAttovia Therapeutics, Inc. (ATTO) · full profile →Form 4 · filed Aug 10, 2026
Net Buying
Open-Market Buys
$6.5M
Open-Market Sells
$0
Net Open-Market Flow
$6.5M
Transactions
7
4 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 6, 2026Conversion(C)2.3M——2.3M
Aug 6, 2026Conversion(C)822K——3.1M
Aug 6, 2026Conversion(C)665K——3.8M
Aug 6, 2026Buy(P)382K$17.00$6.5M4.2M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 6, 2026Conversion(C)21.5M—$00
Aug 6, 2026Conversion(C)7.6M—$00
Aug 6, 2026Conversion(C)6.2M—$00

Transaction Codes

C
Conversion of a derivative
P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000905148-26-003548) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Attovia Therapeutics, Inc.

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

Form 4 insider API

Open-market buys and sells, cluster scans, company flows.

insider.transactions

13F holdings API

Owners, holdings, deltas, point-in-time portfolios.

stock.owners

MCP quickstart

Connect an agent, mint a key, make the first call.

/api/mcp